. ASX - By Stock. Andrew Forrest , or his entities have been involved with IXC since inception. Jellyroll, arkangel, CD, balkanbroker to name a few have laid out some pretty compelling thesis' on where IXC will be heading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. . 59). Fully funded. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. ASX - General. . Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. ASX - By Stock. 40 in May 2020 and has only fallen over the subsequent 36 months. ASX - Day TradingCreated with Sketch. IXC Valuation Report MST. Orphan drug status. IXC Valuation Report MST. ASX - General. 1073084. Created with Sketch. ASX - General. I think having this out we can discuss on the way. Forums. 20. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. ASX - By Stock. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. ASX - Day TradingSomeone bought $500 stock today at 44 cents. ASX - By Stock. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. ASX - Day TradingCreated with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. , page-4. Latest Posts. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. 1. Created with Sketch. I'm topping up. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. A new thread to put trading comments / reasoning / opinions in. Australian finance news, stock quotes, currency information and blogs0. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Charts. Join the HotCopper ASX share market forum today for free. . Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. Commodities. 0. Charts. 8 Upvote Created with Sketch. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. Created with Sketch. ASX - By Stock. 0. . . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. *Close price adjusted for splits. Forums. ASX - Day TradingCreated with Sketch. When can we expect some update or. Invex Receives Approval for Paediatric Plan from the EMA, page-3. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. ASX - By Stock. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. Created with Sketch. Advertise on HotCopper. . 79 -0. Notice of Investor Call and Presentation, page-3. ASX - General. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. ASX - By Stock. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Appendix 4C - quarterly* or having a go at doing so, page-30. AVALANCHE. 3¢. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. ASX - Short Term Trading. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC “ presented “ about the AGM time to who ? If the company is aware ( as others seem to think) of an individual seller then they need to be proactive and take them out . ASX - By Stock. Created with Sketch. Proposed Capital Return to Shareholders of $14. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Below is the broker data for IXC November to. Created with Sketch. Forums. ASX - By Stock. . 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Latest Posts. , page-2. 3¢. Latest Posts. Created with Sketch. ASX - General. Created with Sketch. Created with Sketch. Latest Posts. Issue of Tranche 1 Placement Shares and Appendix 2A. , page-5. . . Created with Sketch. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. 1950. The announcement was certainly a setback but we're not dead in. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. , page-2. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. IXC Price at posting: 23. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Reply. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Plans & Pricing. British Columbia, Selkirk Mountains. , page-2. ASX - Day TradingCreated with Sketch. rights. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. 1956773. Created with Sketch. Update - Notification regarding unquoted securities - IXC. Share Not unexpected. Folks say we are pioneers of craft ice cream in Victoria. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. I think having this out we can discuss on the way. ASX - Short Term Trading. . With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Last updated 10. ASX - By Stock. 1. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. ASX - By Stock. Invex Therapeutics Lists on ASX, page-3. More. My understanding is that NEU went from around $1. Market . , page-4. . Created with Sketch. ASX - General. ASX - By Stock. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. Created with Sketch. ASX - Day Trading. . IXC (ASX) Ann: Trading Halt - HotCopper. Therefore Id bet the same bet with the same info again. ASX - General. Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. ASX - By Stock. Below is the broker data for IXC November to. ASX - Day Tradingis invex releasing 2. IXC Price at posting: $1. , page-2. . . Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Read in the announcement, has changed name and he has bought more ixc, page-2. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Market . With a team of 68. 76 (-1. ASX - Short Term Trading. AX stock on Yahoo Finance. Created with Sketch. com. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Market . Quarterly Activities/Appendix 4C Cash Flow Report. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. ASX - By Stock. . Proposed listing date: 4 JULY 2019#Created with Sketch. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-9 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Latest Posts. Market . Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Created with Sketch. Company has options because they have cash. 8,369 likes · 140 talking about this · 1,407 were here. . Charts. Created with Sketch. Learn more. Created with Sketch. Forums. ASX - By Stock. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. Trading HaltCreated with Sketch. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. Forums. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - By Stock. 0 Great analysis. ASX - By Stock. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. Last edited by ejjwj: 28/06/23. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. Created with Sketch. Market Cap $16. 1950. Charts. A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. 7% #asx #ausbiz 23 Jun 2023 06:06:11. Probably been disappointed like all of us Created with Sketch. Forums. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. ASX - By Stock. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. $45M MC $30M Cash and a $1. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. About 90 percent of the U. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. Latest Posts. Discover historical prices for IXC. Market . Australia's largest stock trading and investment forum Australia's #1 stock forumInvestor PresentationMRDMount Ridley Mines REE Project: Drilling confirms continuous high-grade mineralisation. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 5 cents. Can't see how this doesn't push up soon, page-508. So your thesis is right on a long time time frame. . Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Created with Sketch. , page-3. . Just a matter of time really. 1950. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. IXC could also be worth $14 on a successful trial and licensing deal (or takeover). Some people like to gamble on stocks, others invest. 1950. 20 to $7. Created with Sketch. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. Created with Sketch. International Markets. 4. Strong buy side, sell side still very thin. 50%. . ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. How many friends and family got out after the last announcementshould have been released at the same time, page-34. Theres alot of breakdowns above that are yet to be backtested. , page-3. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC (ASX) Ann: Trading Halt - HotCopper. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. 40. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Created with Sketch. Market . Learn how it impacts everything we do. But since the cash holding is double the market cap, there most likely more upside than down side. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. . LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. 64440. 0. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. 63%. ASX - By Stock. Share Appreciate the commentary and post. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Target our investor community with our suite of Hotcopper Advertising opportunities. Last updated 10. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. This was roughly 50/50 between lost wages and direct medical costs. Latest Posts. A new thread to put trading comments / reasoning / opinions in. Top Smart Score Stocks. . Report Created with Sketch. Created with Sketch. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. A new thread to put trading comments / reasoning / opinions in. . , page-4. Met primary endpoints for phase 2 trials. ASX - Day Trading. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. These are 2007 numbers. Created with Sketch. . Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. Created with Sketch. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. . Forums. Latest Posts. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Probably been disappointed like all of usCreated with Sketch. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. pause in tradingHere we go! AU and UK sites activated for immediate recruitment. Market . Notice of Quarterly Investor Call. ASX - Short Term Trading. Notice of Annual General Meeting/Proxy Form, page-2. Cold Comfort Ice Cream Company, Victoria, British Columbia. Invex Therapeutics Ltd. Charts. Created with Sketch. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. IXC below Example of that is NEUInvestor Presentation, page-3. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. P3 will be kicked off in early CY2021. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. ASX - Day Trading0. Very tempted to buy them back today at 19c. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. Latest Posts. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Too many factors to make an educated appraisal of buyout pre-Phase 2 or post Phase 2. Information. Forums. ASX - General. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Invex Receives Approval for Paediatric Plan from the EMA, page-3. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. 0¢ Sentiment: Buy Disclosure: Held. Latest Posts. ASX - By Stock. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. , page-20. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. All IMO IXC Price at posting: 37. ASX - Day Trading. Created with Sketch. $100-200k might be the minimum for the market to take notice. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. . A handy 10 bags from here with seemingly little risk. Australian finance news, stock quotes, currency information and blogs Active Funds. IXC. Advertise on HotCopper. Invex Therapeutics Ltd. Latest Posts. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3. Join the HotCopper ASX share market forum today for free. June 23 (Reuters) - Invex Therapeutics Ltd (IXC) : GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN. . Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. . Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. ASX - By Stock. Been. Market . 0% $ODM 35. ASX - By Stock. . 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. Created with Sketch. Charts. . Created with Sketch. ASX - Day Trading. I guess that's why retail performs so poorly on average, so many think they are long term investors but can't hold onto their shares for more. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. A rolling snowball gathers snow as it falls down the hill . Created with Sketch. I bought the chart from base lows looking for a trade. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Last research or update on this I listened to was by FiftyOneCapital. ASX - Day TradingAnother day…another approval. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. International Markets. ASX - By Stock. . 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead.